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AbsTrACT 
background the UK-wide national review of asthma 
Deaths sought to identify avoidable factors from the high 
numbers of deaths, but did not examine variation by 
socioeconomic status (SeS) or region.
Methods We used asthma deaths in england over 
the period 2002–2015 obtained from national deaths 
registers, summarised by quintiles of index of Multiple 
Deprivation (iMD) and government Office region. 
emergency asthma admissions were obtained from 
Hospital episode Statistics for england 2001–2011. 
the prevalence of asthma was derived from the Health 
Survey for england 2010. associations of mortality, 
admissions and prevalence with iMD quintile and 
region were estimated cross-sectionally using incidence 
rate ratios (irrs) adjusted for age and sex and, where 
possible, smoking.
results asthma mortality decreased among more 
deprived groups at younger ages. among 5–44 year 
olds, those in the most deprived quintile, mortality was 
19% lower than those in the least deprived quintile (irr 
0.81 (95% ci 0.69 to 0.96). in older adults, this pattern 
was reversed (45–74 years: irr 1.37 (1.24–1.52), ≥75 
years: irr 1.30 (1.22–1.39)). in 5–44 year olds the 
inverse trend with asthma mortality contrasted with 
large positive associations for admissions (irr 3.34 
(3.30–3.38)) and prevalence of severe symptoms (irr 
2.38 (1.70–3.33)). Prevalence trends remained after 
adjustment for smoking. irrs for asthma mortality, 
admissions and prevalence showed significant 
heterogeneity between english regions.
Conclusions Despite asthma mortality, emergency 
admissions and prevalence decreasing over recent 
decades, england still experiences significant SeS and 
regional variations. the previously undocumented inverse 
relation between deprivation and mortality in the young 
requires further investigation.
bACkground
The UK has among the highest asthma mortality 
rates of high-income countries globally in younger 
age-groups (those aged 5–34 years), the highest 
asthma admission rates in Europe and the highest 
rates of asthma symptoms globally in children.1 
The National Review of Asthma Deaths (NRAD), 
a confidential review of asthma deaths, found that 
despite improved asthma care in recent decades 
many deaths were still preventable.2 Variations in 
asthma prevalence, hospitalisation and death by 
socioeconomic status (SES)3 4 and region5 6 have 
been highlighted previously, but covered short time 
periods or age-ranges or were undertaken several 
years ago.
The independent impact of SES on premature 
mortality has been compared with that from phys-
ical inactivity and smoking7 though it is acknowl-
edged that there are complex relationships between 
these and other mortality risk factors. That SES has 
a significant role in reported asthma symptoms, 
doctor-diagnosis, hospital admission rates and 
mortality has long been accepted,3 8 9 but there are 
relatively few conflicting accounts of its effects in 
children and younger adults.4 10 11
In the light of NRAD, which did not address SES 
or geographical trends, we updated and extended 
earlier reviews3 4 6 to consider trends by deprivation 
and region using recent asthma prevalence, admis-
sion and death data in England spanning the last 
15 years.
MeThods
As a recent extensive review of asthma burden in the 
UK illustrated, harmonisation of asthma definitions 
key messages
What is the key question?
 ► Do historic variations in asthma outcomes by 
SES and English region remain despite declines 
in mortality, admission and prevalence rates?
What is the bottom line?
 ► Large and highly significant differences in both 
regional and SES patterns remain and the latter 
show surprisingly anomalous results in the 
young.
Why read on?
 ► The UK National Review of Asthma Deaths has 
highlighted the importance of psychosocial 
factors in asthma deaths and we have 
confirmed the contributory role of relative 
deprivation. Although severe asthma prevalence 
and emergency hospital admission rates for 
asthma were much higher in less affluent areas, 
asthma mortality among children and younger 
adults was more common in more affluent 
areas. Previously reported regional variations 
in asthma mortality within England persist but 
correlate poorly with the regional prevalence of 
severe asthma.
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was not possible across the UK and not all outcomes were avail-
able by SES.12 We have therefore confined this investigation to 
England, which accounts for 85% of the UK population. All 
analyses were undertaken in Stata 12.13
deaths and populations
The numbers of registered deaths in England with underlying 
cause of asthma (International Classification of Diseases Version 
10 (ICD-10) J45 and J46) recorded on the death certificate 
were obtained from the Office of National Statistics (ONS).14 
Deaths were included from 2002, after ICD-10 was introduced 
into the UK mortality data, until 2015, the latest available year. 
Individual level data included postcodes, which were matched 
to English Index of Multiple Deprivation (IMD) 2010 ranks.15 
Deaths by quintile of IMD were derived and ranged from 1 (least 
deprived) to 5 (most deprived). Death data included English 
county, from which the nine Government Office Regions (GOR) 
of England were derived. Mid-year population estimates were 
obtained from ONS by year, 5-year age group, sex, English IMD 
2015 and GOR.14
Indirect standardisation (the calculation of Standardised Event 
Ratios, SERs) was used to compare asthma mortality by IMD 
quintile and GOR in England. An SER of 100 represents the 
England average age-standardised ratio.
Incidence rate ratios (IRR) by IMD and GOR were calculated 
using Poisson regression on IMD quintile and GOR as categor-
ical variables adjusting for age and sex. Trends in SES were fitted 
using linear regressions and the linear model fit tested using like-
lihood ratio tests.
Results for IMD were stratified into broad age-ranges (5–44, 
45–74 and 75 years and over). The youngest group was the 
one for whom asthma was unlikely to be confused with chronic 
obstructive pulmonary disease (COPD), found in older people, or 
with other respiratory conditions of the very young. The oldest 
group were excluded from NRAD partly because ‘resources 
did not permit’,2 but included here for completeness. Regional 
results were presented for all ages above 5 years; age-stratified 
results would lead to less statistical reliability.
emergency hospital admissions
Numbers of emergency admissions with a primary diag-
nosis of asthma (ICD-10 J45 and J46) by age, sex, IMD 
2004 quintile were obtained from Hospital Episode Statis-
tics (HES) for England for calendar years 2001-2011.16 We 
also obtained data from an analysis of England 2008–12 
admissions5 which included information on age, sex and 
GOR. SERs by IMD quintile and GOR were calculated 
using national population denominators and age-sex- 
adjusted IRRs were derived.
health survey for england
The prevalence of asthma symptoms, diagnosis and treatment 
were derived from the Health Survey for England (HSE) 2010, 
the latest of these annual surveys to include a detailed respi-
ratory questionnaire. HSE is a large, nationally representative 
health examination survey of households in England in 2010. 
Trained interviewers surveyed 14 112 adults and children of 
all ages with response rates between 66% and 70%.17 Two 
measures of prevalence were used, the prevalence of clini-
cian-diagnosed-and-treated asthma and recent severe asthma, 
as detailed in the footnotes to table 1. IMD 2007 quintile, 
GOR and non-response weights were included in HSE 2010. 
Age-sex-adjusted IRRs were calculated to compare with 
those for mortality and admissions. Additional adjustment 
for smoking status was possible in HSE (never smoked versus 
currently/ever smoked cigarettes). SERs were derived by IMD 
quintile by the broad age-bands and by GOR for all ages due 
to small numbers.
reporting
The STROBE statement for cross-sectional studies was used to 
guide reporting of results.
resulTs
In England, there were 14 830 recorded asthma deaths between 
2002 and 2015 of which 68% occurred in females; there were 
1424 in 5–44 year olds (255 in 5–14 years), 3993 in 45–74 year 
olds and 9388 in those over 75 years. There were 542 877 emer-
gency asthma admissions over the age of 5 years from 2001 
to 2011, of which 60% occurred in females. In HSE 2010, of 
12 077 people over the age of 5 years (the total number after 
weighting for age-sex representation and non-response), 1156 
reported having been diagnosed and treated for asthma (51% 
female) and 721 reported severe symptoms of asthma in the last 
year (52% female).
Variation by deprivation quintile
IMD was matched for 96% of deaths, 99% of admissions 
and 100% of survey respondents. SERs for quintiles of IMD 
showed distinct patterns by outcome, age-band and sex. Except 
for mortality in ages 5–44 years, there were broadly increased 
event ratios with increasing deprivation for all age-groups for 
mortality, hospital admissions and severe symptoms. All showed 
statistically significant linear trends except for symptoms in age 
75 years and over, where smaller numbers were surveyed. By 
contrast, in 5–44 year olds there was a pattern of decreasing 
asthma mortality in more deprived areas. Clinician-diag-
nosed-and-treated asthma showed mixed results across age and 
sex groups with a clear increase with deprivation only in the 
45–74 years group.
In females aged 5–44 years, SERs for mortality broadly 
decreased with increasing deprivation while in males the 
pattern was more mixed (figure 1A). There was an average 
5% (95% CI 1% to 9%) fall in age-sex-adjusted IRRs for 
asthma mortality in this youngest age group from the least 
deprived to the most deprived (test for trend from linear 
regression, P=0.006, table 1A). In those aged 45–74 years, 
the trend ran in the opposite direction with SERs rising from 
the least deprived to the most deprived quintile in both males 
and females. There was a significant 8% increase (95% CI 
6% to 11%) in IRRs across increasing IMD quintile. In 
those over 75 years, there was a similar rise in mortality with 
increasing deprivation, but with a U-shaped pattern. These 
mortality differentials were broadly consistent over time, 
but numbers were small per year in the youngest age-band 
precluding detailed analysis. Average mortality rates in the 
5–44 year olds were higher in the most affluent areas in each 
of 2002–05, 2006–2010 and 2011–2015 (7.0, 6.2 and 5.2 
per million for the least deprived quintile compared with 
6.6, 5.3 and 3.8 in the most deprived quintile). In contrast, 
among the 45–74 year olds mortality rates were lower in the 
least deprived quintile compared with the highest in each of 
these three time periods (20.8, 15.5 and 11.9 compared with 
27.9, 19.8 and 17.5).
Neither the IMD trend in emergency asthma admissions 
(figure 1B) nor in prevalence of asthma (figure 1C, D) showed 
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these same age-specific differences. In the<45 years age group 
there was a more than threefold increase in asthma admissions 
in the most deprived IMD quintile compared with the least 
(IRR=3.34, 3.30–3.38, table 1B), a doubling in the 45–74 year 
olds (IRR=2.01,1.98–2.05) and a 43% increase in the oldest 
age-band. Differences in the prevalence of diagnosed-and-
treated asthma as well as severe asthma showed similar 
patterns though these were smaller than that for admissions 
and greater than that for mortality (table 1C, D). Interpre-
tation of the relative prevalence in the oldest age group was 
hindered by the smaller numbers surveyed. Adjusting the prev-
alences for smoking, possible only in the survey data, led to a 
small attenuation in the otherwise similar pattern of rates by 
IMD (online supplementary table 1).
Table 1 Association of Index of Multiple Deprivation (IMD) quintile with asthma outcomes (incidence rate ratio (IRR) with 95% CI), adjusting for 
age and sex, stratified by age-band: (A) mortality, England 2002–2015; (B) emergency admissions, England 2001–2011; (C) prevalence of clinician-
diagnosed-and-treated asthma in the last 12 months, England 2010*; (D) prevalence of recent severe asthma symptoms*, England 2010.
(A) Mortality 5–44 years 45–74 years 75 years and over
IMd n deaths Irr 95% CI n deaths Irr 95% CI n deaths Irr 95% CI
Least deprived 1 263 1.00 Reference 765 1.00 Reference 1847 1.00 Reference
  2 291 0.96 0.81 1.13 767 1.07 0.97 1.18 1751 0.94 0.88 1.00
  3 244 0.85 0.72 1.02 768 1.11 1.00 1.22 1750 0.95 0.89 1.02
  4 297 0.85 0.72 1.01 783 1.28 1.16 1.41 1854 1.14 1.07 1.22
  5 275 0.81 0.69 0.96 751 1.37 1.24 1.52 1866 1.30 1.22 1.39
Linear trend for IMD 0.95 0.91 0.99 1.08 1.06 1.11 1.08 1.06 1.09
  (P value) 0.006 <0.001 <0.001
(b) Admissions 5–44 years 45–74 years 75 years and over
IMd n admissions Irr 95% CI n admissions Irr 95% CI
n 
admissions Irr 95% CI
Least deprived 1 40 428 1.00 Reference 18 309 1.00 Reference 7201 1.00 Reference
  2 47 402 1.22 1.20 1.23 23 433 1.17 1.15 1.19 8745 1.09 1.06 1.13
  3 59 025 1.64 1.62 1.66 27 775 1.23 1.21 1.25 10 044 1.13 1.10 1.17
  4 79 155 2.28 2.25 2.31 35 044 1.47 1.45 1.50 10 991 1.23 1.20 1.27
  5 1 13 570 3.34 3.30 3.38 49 385 2.01 1.98 2.05 12 370 1.43 1.39 1.47
Linear trend for IMD 1.37 1.37 1.37 1.19 1.19 1.20 1.09 1.08 1.10
  (P value) <0.001 <0.001 <0.001
(C) diagnosis 5–44 years 45–74 years 75 years and over
IMd n diagnosed Irr 95% CI n diagnosed Irr 95% CI
n 
diagnosed Irr 95% CI
Least deprived 1 123 1.00 Reference 56 1.00 Reference 14 1.00 Reference
  2 136 1.21 0.96 1.54 59 1.41 1.00 1.99 16 1.06 0.54 2.05
  3 147 1.31 1.04 1.66 66 1.58 1.13 2.22 13 1.17 0.59 2.32
  4 157 1.27 1.01 1.60 87 1.99 1.44 2.75 18 2.06 1.11 3.83
  5 184 1.38 1.10 1.73 70 2.14 1.53 2.98 10 1.38 0.67 2.84
Linear trend for IMD 1.07 1.02 1.12 1.20 1.12 1.29 1.16 1.00 1.34
  (P value) 0.007 < 0.001 0.06
(d) symptoms 5–44 years 45–74 years 75 years and over
IMd
n severe 
symptoms Irr 95% CI
n severe 
symptoms Irr 95% CI
n severe 
symptoms Irr 95%  CI 
Least deprived 1 47 1.00 Reference 36 1.00 Reference 14 1.00 Reference 
  2 59 1.47 1.01 2.13 37 1.36 0.89 2.10 14 0.99 0.51 1.89
  3 71 1.77 1.23 2.53 53 1.92 1.28 2.88 11 0.87 0.43 1.78
  4 94 2.00 1.42 2.84 65 2.35 1.59 3.48 20 2.12 1.16 3.86
  5 113 2.38 1.70 3.33 79 3.85 2.65 5.59 8 1.10 0.52 2.32
Linear trend for IMD 1.22 1.13 1.31 1.39 1.28 1.51 1.13 0.97 1.32
  (P value) <0.001 < 0.001 0.12 
*Clinician-diagnosed-and-treated asthma; a combination of the questions: ‘Did a doctor or nurse ever tell you that you had asthma?’ AND “Over the last 12 months, have you 
used an inhaler, puffer or nebuliser prescribed by a doctor to treat your asthma, wheezing or whistling, or difficulty in breathing?”. Recent severe asthma; a combination of any 
of the following: in the last 12 months has had sleep disturbed one or more nights per week due to wheezing/whistling in chest, has found in the last 12 months chest wheezing 
±whistling interfered with normal activities ‘quite a bit’ or ‘a lot’, has experienced symptoms of asthma ‘every day’ or ‘most days’, had difficulty sleeping one or more days due to 
usual asthma symptoms in the last week or had usual asthma symptoms during the day one or more days in the last week
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Variation by english region
GOR was available for all deaths, admissions and survey 
respondents and showed significant regional variations for all 
outcomes. Mortality rates were highest in the West Midlands 
for both males and females (figure 2A), about a third higher 
than the England average (males SER=134, 95% CI 124 to 145; 
females SER=127, 120–134). Age-sex-adjusted IRRs reflected 
these patterns and showed significant heterogeneity by region 
(P<0.001, online supplement table 2).
The highest emergency admission rates occurred in the North 
West (figure 2B, males SER=141, 139–143, females SER=129, 
128–131). Again the adjusted IRR reflected these patterns and 
showed significant regional heterogeneity (P<0.001, online 
supplementary table S2).
There were slightly smaller differences in SERs for the prev-
alence of clinician-diagnosed-and-treated asthma, from the 
highest in the North West to the lowest in South East. Severe 
asthma symptoms SERs were highest in the North East and 
lowest in the South East for males and East of England for 
females. Despite the smaller numbers in the survey sample, there 
was significant heterogeneity in the adjusted IRRs of prevalence 
measures between regions (P=0.005 for diagnosed-and-treated 
asthma and P=0.04 for severe asthma).
Although SERs for mortality and admission were highest in the 
West Midlands, prevalence of both diagnosed asthma and severe 
symptoms were lower than the national average there. In general, 
there was little congruence between outcomes by GOR (all correla-
tions r<|0.43| online supplementary table 3). The exception to 
this was a correlation between those reporting severe symptoms 
and hospital admissions in males and females combined of 0.60 
(P=0.01 for Spearman test of independence).
dIsCussIon
statement of principal findings
We have shown that despite well-known recent declines in 
national asthma mortality and hospital admission rates,18 signif-
icant differences by SES and region remain. We have also high-
lighted an unusual and unexpected pattern of a modest but 
significant decrease in deaths from asthma with increasing levels 
of relative deprivation in children and adults<45 years.
This was not consistent with the trend in national emergency 
admissions, where there was a trebling with increasing deprivation, 
nor in self-reported levels of clinically significant asthma, where 
there was a doubling in prevalence, in the same age group. For older 
age groups, in each of these outcomes there remained a clear trend 
of increasing asthma deaths, admissions and prevalence with greater 
relative deprivation. The IMD trends in measures of asthma preva-
lence were attenuated, but remained, after adjustment for smoking.
Relative differences between the lowest and highest regional 
rates ranged between 1.5 to 1.9 times for the outcomes investigated 
here. Although the West Midlands still has among the highest rates 
for both asthma mortality and emergency admissions in England, 
regional patterns of admissions and prevalence across England do 
not generally reflect those for mortality.
strengths and weaknesses
We have used national datasets over a number of overlapping 
years to assess asthma patterns by SES and region though we 
Figure 1 Socioeconomic status variations in asthma outcomes in England, standardised event ratios by Index of Multiple Deprivation (IMD; 1 is 
least deprived), sex and age-band, with 95% CI bars: (A) mortality 2002–2015, Office for National Statistics mortality; (B) emergency admissions 
2001–2011, Hospital Episode Statistics; (C) prevalence of clinician-diagnosed and treated asthma 2010*, Health Survey for England 2010; (D) 
prevalence of recent severe asthma 2010*, Health Survey for England 2010. Footnotes. †95% CI too small to be visible. *Clinician-diagnosed-and-
treated asthma; a combination of the questions: ‘Did a doctor or nurse ever tell you that you had asthma?’ AND ‘Over the last 12 months, have 
you used an inhaler, puffer or nebuliser prescribed by a doctor to treat your asthma, wheezing or whistling, or difficulty in breathing?’. Recent 
severe asthma; a combination of any of the following: in the last 12 months has had sleep disturbed one or more nights per week due to wheezing/
whistling in chest, has found in the last 12 months chest wheezing ±whistling interfered with normal activities ‘quite a bit’ or ‘a lot’, has experienced 
symptoms of asthma ‘every day’ or ‘most days’, had difficulty sleeping one or more days due to usual asthma symptoms in the last week or had usual 
asthma symptoms during the day one or more days in the last week. Presented as simple prevalences (%) due to small numbers.
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were unable to link these to compile a longitudinal dataset. 
UK deaths statistics have excellent completion rates14 though 
NRAD’s detailed investigation into cause of death showed a drop 
in the accuracy of deaths coding with increasing age.2 In those 
under 45 years, the NRAD Panel agreed that clinical findings 
matched asthma as the underlying cause in over 90% of cases. 
The youngest death in that study was aged 4 suggesting that our 
5–44 years group has the most accurate asthma mortality coding 
of all age-groups. This proportion fell to 60–85% in those aged 
45–74 years and under 50% in those sampled over 75 years 
when mis-classification with COPD and other comorbidities 
increase. However, the percentage of deaths with a mention 
of asthma which have asthma as the underlying cause has not 
changed appreciably over time19 and there has to our knowledge 
been no suggestion of any association of deaths coding with SES 
or region. Low numbers of asthma deaths in the youngest age 
group prevented more detailed breakdowns by age or other risk 
factors to investigate further. HES data have high completeness 
nationally and a recent review found a median 80% accuracy in 
diagnostic coding.20 Neither deaths nor admissions data include 
information on smoking. Prevalence from HSE is self-reported, 
but this nationally representative survey has good response rates 
from a large sample and uses validated prevalence questions.17 
In contrast to the surveys used in earlier reviews,6 for the HSE 
2010 non-response weights were calculated adjusting for age, 
sex, Strategic Health Authority, household type and the social 
class of the household reference person.
IMD is a widely used, regularly updated, area-based, multifac-
eted measure of SES with seven components including health, 
employment, income and education. It applies beyond work-
ing-aged groups, reflects households rather than individuals 
and may be less prone to reverse-causation than purely income 
or employment based measures. Although the IMD measures 
presented are from different years for some outcomes, those 
for 2004, 2007, 2010 and 2015 employed here use the same 
methodology and were designed to be broadly comparable in 
terms of relative deprivation.21 We found 3.6% missing IMD 
quintile in the mortality data, but there was little difference by 
age-group (3.8% 5–44y, 4.0% 45–74y and 3.4% 75+). We have 
no reason to believe IMD coding is less accurate in younger age 
groups though deprivation measures tend to improve with age. 
This does not explain however the inverse relationship seen for 
mortality compared with that for admissions or prevalence.
Interpretation in the light of previous research
Previous UK studies used social class (SC I to V) as a measure 
of SES.4 5 8 9 This was derived from the occupation of the indi-
vidual or head of household but could not be applied to those 
over working age. Higgins et al4 found a similar pattern to this 
investigation: little difference in mortality between SC in males 
aged 5–34 years (England and Wales 1979–87), but in men aged 
35–64 years there were 36% more deaths in manual occupations 
compared with non-manual. Two-thirds of records for women 
were missing individual SC and in those remaining there was 
Figure 2 Regional variations in asthma outcomes in England, standardised event ratios by English Government Office Region and sex, with 
95% CI bars, ranked by the Standard Events Ratios (SERs) for mortality in males and females combined: (A) mortality 2002–2015, ONS mortality; 
(B) emergency admissions 2008–12, Hospital Episode Statistics; (C) prevalence of clinician-diagnosed-and-treated asthma 2010, Health Survey 
for England 2010; (D) prevalence of recent severe asthma 2010*, Health Survey for England 2010. Footnotes. †95% CI too small to be visible. 
*Clinician-diagnosed-and-treated asthma; a combination of the questions: ‘Did a doctor or nurse ever tell you that you had asthma?’ AND ‘Over 
the last 12 months, have you used an inhaler, puffer or nebuliser prescribed by a doctor to treat your asthma, wheezing or whistling, or difficulty in 
breathing?’. Recent severe asthma; a combination of any of the following: in the last 12 months has had sleep disturbed one or more nights per week 
due to wheezing/whistling in chest, has found in the last 12 months chest wheezing ±whistling interfered with normal activities ‘quite a bit’ or ‘a lot’, 
has experienced symptoms of asthma ‘every day’ or ‘most days’, had difficulty sleeping one or more days due to usual asthma symptoms in the last 
week or had usual asthma symptoms during the day one or more days in the last week. Government Office Regions (GOR), SW South West, NE North 
East, E East of England, EM East Midlands, NW North West, Lon London, YH Yorkshire and Humberside, WM West Midlands.
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no clear trend. Jones et al8 considered a broader age range and 
found that in those aged 5–55 years (from deaths in 401 local 
authority districts in England in 1988–92) asthma mortality was 
strongly associated with the proportion of households where the 
head was SC most deprived (RR=1.61, 95% CI 1.12 to 2.33). 
National mortality records (all-ages SERs, England and Wales 
1991–93) showed a four-fold increase in asthma deaths between 
those in the most and least deprived SC.9
The more recent mortality rates among older adults presented 
here show higher rates in more deprived areas, but the observation 
of a significant trend in the opposite direction among children and 
younger adults may reveal an unexpected phenomenon. Among 
5–44 year-olds, the prevalence of diagnosed-and-treated asthma 
varied little with area deprivation in contrast to a doubling in prev-
alence of severe symptoms (table 1). While this might suggest small 
differences in asthma labelling by SES (even after adjustment for 
smoking), most likely to be made by primary care physicians, the 
mortality results for this age-group are unlikely to be entirely attrib-
utable to diagnostic or labelling artefact. Since severe asthma symp-
toms and hospital admissions for asthma in the under-45s were less 
common in the more affluent areas it is unlikely that the higher 
mortality rate in this group is due to poorer long-term control of 
asthma symptoms. Indeed, one would expect that compliance with 
prescribed treatment would be better in these areas than in more 
deprived areas. We were unable to assess trends by SES in general 
practice data, but two studies which have done this showed higher 
prevalence and incidence of asthma consultations in more deprived 
areas,5 a socioeconomic trend which has been found even among 
non-smokers.9 SES measures from routine data are difficult to 
harmonise internationally so comparable SES measures between 
the UK and elsewhere are rare and we are not aware of any for 
asthma risk factors. Nor are we aware of any analyses of SES time-
trends for asthma, again probably due to the difficulties in compar-
isons over time, though our own analysis shows consistently higher 
mortality rates in the most deprived quintile compared with the 
least deprived quintile (online supplementary figure 1).
Significant differences in asthma mortality, admissions and 
prevalence by English region have been noted in the past.4 6 
The weak correlations found between regional all-ages asthma 
prevalence, admissions and mortality in the early 1990s6 match 
our results. This is perhaps unsurprising as the highest admis-
sion rates are in the young whereas the highest mortality rates 
occur in the elderly with prevalence more stable over the life 
course. We found that large regional differences persist despite 
the introduction, in the late 1990s, and the development, over 
several decades, of national treatment guidelines by the National 
Institute for Health and Care Excellence and BTS/SIGN as well 
as several years’ of incentive payments for asthma treatment by 
the Quality and Outcomes Framework programme. This concurs 
with GP reports of people ‘ever diagnosed’ with asthma showing 
wide variations across England in 2012.5 An analysis of 24 
European countries found a very similar correlation (r=0.44, 
P=0.03) between them in age-standardised mortality and 
admissions for asthma.1 A comparison of mortality, admissions 
and prevalence of wheeze in children22 similarly found a high 
correlation between severe wheeze and admissions in 13–14 year 
olds (r=0.73, P=0.003) in 14 countries though little correlation 
between other outcomes.
Regional variations in asthma mortality in the UK have been 
shown to reflect geographical differences in access to and quality 
of healthcare services6 as well as socioeconomic factors.8 Informa-
tion on more specific exposures such as smoking and ethnicity was 
not available in the national mortality and admissions data, but 
using the prevalence data we were able to confirm the observation 
of Hansell et al6 8 that regional differences in asthma prevalence 
and severity were not altered greatly by adjustment for smoking. 
An analysis of deaths from all causes in England23 found that IMD 
accounted for a large proportion of the geographical variation 
in age-adjusted mortality and the independent contribution of 
regional differences was small in both sexes.
Interpretation and future research
Stringini et al7 have estimated the rate-ratio of low compared 
with high SES on non-cardiovascular disease, non-cancer 
mortality to be 1.45 (95% CI 1.35 to 1.56) after adjustment 
for age, sex and ethnicity and 1.25 (95% CI 1.17 to 1.33) 
when further adjusted for high alcohol intake, physical inac-
tivity, current smoking, hypertension, diabetes and obesity. They 
acknowledge that each of these may be interrelated, together 
with specific components of SES including low income, educa-
tion levels and occupational position. Rona3 suggested the 
following possible reasons for SES as a risk factor in asthma: an 
aetiological factor; an exacerbating factor; a determinant of the 
quality of care; a contributor of psychosocial behaviour which 
impacts on the management and prognosis of the condition or as 
a component in asthma labelling. More specifically, the Global 
Atlas of Asthma24 suggests that low SES families are more likely 
to be exposed to environmental pollutants (eg, particles from 
diesel), indoor allergens (eg, mould and dust) and other respira-
tory irritants (eg, tobacco smoke) that adversely affect asthma as 
well as being more likely to be exposed to psychosocial stressors 
(eg, food, housing and financial insecurity, social marginalisation 
and community or domestic violence). NRAD2 found psychoso-
cial factors contributed to 26% (51/195) of UK asthma deaths 
of all ages, with similar proportions among deaths under 10 
(30%) and aged 10–19 (22%). ‘Psychological factors’ contrib-
uted to 16% of deaths and ‘social factors’ to 15% of deaths. 
There are well-recognised occupational causes of asthma associ-
ated with lower SES jobs (eg, bakers, farmers, painters, welders, 
woodworkers). These, as with most factors in the literature, help 
explain the increased asthma in lower SES groups seen in most 
outcomes and age-groups here and elsewhere.
There are few examples however of risk factors of any type 
for higher SES groups that might account for our mortality 
findings in the 5–44 year olds. The Global Atlas of Asthma 
suggests ‘community vitality/collective efficacy, increased mater-
nal-child interaction, and effective utilisation of psychological 
coping strategies’ have positive effects on asthma outcomes and 
it could be that some of these form mitigating factors in lower 
SES groups. There are also a few occupational causes of asthma 
associated with higher SES (eg, latex in healthcare workers, alde-
hydes in dentists, animal excreta in laboratory researchers). It is 
not clear how much each of these might contribute to the inverse 
pattern seen here in younger deaths or if other factors might 
account for it. Higgins and Britton were not able to provide 
an explanation found for the similar pattern found in males 
in earlier decades.4 A study of mortality in England in the late 
1990s25 found slightly higher mortality rates from ‘major causes’ 
in teenage boys in the least deprived quintile of IMD compared 
with the most deprived and almost equal rates in teenage girls. 
This category included lower respiratory diseases, cancers, circu-
latory disease and others (ICD9 1–239 390–519) but no reasons 
for this pattern were offered nor were more detailed causes 
investigated. A study comparing mortality with a census question 
on long-term illness or disability26 found SES all-cause mortality 
differentials were lowest in the teenage years and early 20s, but 
also found a similar pattern for self-reported ‘limiting long-term 
 o
n
 16 M
ay 2018 by guest. Protected by copyright.
http://thorax.bmj.com/
Thorax: first published as 10.1136/thoraxjnl-2017-210714 on 14 May 2018. Downloaded from 
7Gupta RP, et al. Thorax 2018;0:1–7. doi:10.1136/thoraxjnl-2017-210714
Asthma
illness’, in contrast to our findings here for asthma. This suggests 
a disease-specific component to the difference between mortality 
and morbidity SES patterns for asthma.
One speculative explanation for the anomalous socioeco-
nomic trend in younger asthma deaths is that in more affluent 
areas there is a higher prevalence of a less predictable (more 
‘brittle’) form of asthma which occasionally progresses rapidly 
to a fatal outcome despite apparently adequate long-term symp-
tomatic control. The higher prevalence of atopy and allergies 
in higher SES groups may also be a factor acting together with 
brittle asthma or in addition to it and it is possible that some of 
these cases are included within deaths coded as asthma.
Asthma poses a large healthcare burden in England costing 
the public sector an estimated £900 million12 and many deaths 
are avoidable with better care.2 Despite falling asthma mortality 
over time and decades of improvements in asthma management, 
the UK still suffers among the highest global mortality rates in 
the young1 and significant differences by SES and region remain 
across England, despite national guidelines and a health service 
free at the point of contact. These differences are even wider 
in emergency hospital admissions where there were more than 
three times as many emergency admissions in the poorest among 
the youngest and twice as many admissions and cases of severe 
symptoms among the poorest in older age groups.
These results should be monitored in England and, where 
possible, tested in other countries using existing international 
health studies. Greater numbers of deaths from longer English 
or UK time trends could be sought to investigate age-specific 
mortality-SES differentials within the 5–44 year old age-band. 
The relationships between prevalence of symptoms, consulta-
tions in general practice, emergency admission to hospital and 
mortality should be examined further and the reason for the 
inverse relation of mortality with IMD in those aged 5–44 years 
in relation to other age groups and other outcomes needs expla-
nation as this is unlikely to be due to data artefact. Such anal-
yses could use general practice databases linked to admissions 
and mortality which would enable more complete allowance 
than possible here, for confounding by smoking and other risk 
factors. More detailed clinical information could identify a 
distinct and troublesome asthma phenotype which has become 
more common in England in recent years, particularly in more 
affluent areas, as well as helping identify the role of concurrent 
allergic disease or any overlap with COPD in older age groups.
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